New implantable device can help monitor cancer for months after biopsyMay 14th, 2009 - 2:44 pm ICT by ANI
Washington, May 14 (ANI): Scientists at the Massachusetts Institute of Technology (MIT) have developed the first implantable device that can help monitor a tumour for weeks or months after the biopsy, tracking its growth and how it responds to treatment.
Michael Cima, a professor of Materials Science and Engineering who led the creation of the device, has revealed that it was found to successfully track a tumour marker in mice for one month during a recent study.
He and his colleagues reckon that such implants may one day provide up-to-the-minute information about what a tumour is doing — whether it is growing or shrinking, how it’s responding to treatment, and whether it has metastasized or is about to do so.
“What this does is basically take the lab and put it in the patient,” said Cima, who is also an investigator at the David H. Koch Institute for Integrative Cancer Research at MIT.
The device can be implanted at the time of biopsy. It can also be tailored to monitor chemotherapy agents, so that doctors can determine whether cancer drugs are reaching the tumours.
Cima says that his device can also be designed to measure pH (acidity) or oxygen levels, which reveal tumour metabolism and how it is responding to therapy.
He points out that with current tools for detecting whether a tumour has spread, such as biopsy, by the time you have test results it’s too late to prevent metastasis, said Cima.
“This is one of the tools we’re going to need if we’re going to turn cancer from a death sentence to a manageable disease,” he said.
During an experiment, Cima and his colleagues transplanted human tumours into the mice, and then used the implants to track levels of human chorionic gonadotropin, a hormone produced by human tumor cells.
The cylindrical, 5-millimeter implant contains magnetic nanoparticles coated with antibodies specific to the target molecules that bind to the particles and cause them to clump together. That clumping can be detected by magnetic resonance imaging (MRI).
Cima believes that an implant to test for pH levels could be commercially available in a few years, followed by devices to test for complex chemicals like hormones and drugs.
A research paper describing the novel implantable device has been published online in the journal Biosensors and Bioelectronics. (ANI)
- Now, a tiny white bread mint like capsule to track cancer in the body - Mar 16, 2011
- Micro oxygen generators fight cancer faster - Sep 01, 2011
- New technique diagnoses brain cancers non-invasively - Jan 29, 2012
- Protein from pregnancy hormone may avert breast cancer - Nov 25, 2009
- Will a female birth control vaccine work? - Mar 13, 2011
- Kiwi experts' warning over fad diet using placenta hormones - Dec 16, 2010
- Scientists reverse muscle wasting due to cancer in mice - Aug 24, 2010
- Magnets help fight prostate cancer - Nov 09, 2011
- Magnetic pulses can burn cancer cells - Dec 06, 2010
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- Liver cancer can be caused by excess growth hormone - Apr 14, 2012
- Cancer linked to loss of protein that hooks skin cells together - Oct 22, 2010
- Restoring gene may slow spread of advanced lung tumours - Nov 25, 2010
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Off-the-shelf digital camera helps detect cancer cells - Jun 25, 2010
Tags: biopsy, cancer drugs, cancer research, chemotherapy agents, chorionic gonadotropin, clump, current tools, h koch, human tumor cells, human tumours, implantable device, magnetic nanoparticles, manageable disease, massachusetts institute of technology, massachusetts institute of technology mit, materials science and engineering, oxygen levels, ph acidity, target molecules, tumour marker